Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,587,983 papers from all fields of science
Search
Sign In
Create Free Account
C-telopeptide
Known as:
C-Terminal Telopeptide Type 1 Collagen
, CTX
, CTX-I
Expand
This polypeptide is comprised of the carboxy-terminal portions of fibrillar collagen, which are joined through trivalent crosslinks and released…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
C-terminal type I collagen telopeptide
Cell Adhesion
Cell Movement
Collagen Gene
Expand
Broader (1)
collagen type I trimeric cross-linked peptide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men
R. Kouvelioti
,
Paul J. LeBlanc
,
B. Falk
,
Wendy E. Ward
,
A. Josse
,
P. Klentrou
Calcified Tissue International
2019
Corpus ID: 58949264
This study compared sclerostin’s response to impact versus no-impact high-intensity interval exercise in young men and examined…
Expand
2018
2018
Detection and confirmation of α-cobratoxin in equine plasma by solid-phase extraction and liquid chromatography coupled to mass spectrometry.
F. Guan
,
Y. You
,
Xiaoqing Li
,
M. Robinson
Journal of Chromatography A
2018
Corpus ID: 3566000
2016
2016
A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients
S. Veerappan
,
M. Healy
,
B. Walsh
,
C. O'Morain
,
J. Daly
,
B. Ryan
European Journal of Gastroenterology and…
2016
Corpus ID: 24767053
Objectives Infliximab (IFX) treatment has shown potentially beneficial effects on bone metabolism in inflammatory bowel disease…
Expand
2014
2014
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
B. Bielesz
,
M. Hecking
,
+7 authors
G. Sunder-Plassmann
Clinical Biochemistry
2014
Corpus ID: 20234340
2012
2012
Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice
M. Sheng
,
J. Wergedal
,
S. Mohan
,
M. Amoui
,
D. Baylink
,
K. Lau
PLoS ONE
2012
Corpus ID: 9908357
This study sought to test whether targeted overexpression of osteoactivin (OA) in cells of osteoclastic lineage, using the…
Expand
2011
2011
The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
W. Park
Journal of Korean medical science
2011
Corpus ID: 8147117
Dear Editor We appreciate the comments by Marcuzzi. Marcuzzi et al. (1) and we (2) showed that the pamidronate stimulates the…
Expand
2004
2004
Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone.
Heidi A Eriksen
,
C. Sharp
,
S. Robins
,
M. Sassi
,
L. Risteli
,
J. Risteli
Bone
2004
Corpus ID: 27146954
1996
1996
Cross-link analysis of the C-telopeptide domain from type III collagen.
W. Henkel
Biochemical Journal
1996
Corpus ID: 26028326
Several peptides were isolated from tryptic digests of insoluble calf aorta matrix by chromatography. Reductive pyridylethylation…
Expand
1993
1993
Conformational analysis of the type II and type III collagen alpha-1 chain C-telopeptides by 1H NMR and circular dichroism spectroscopy.
X. Liu
,
A. Otter
,
P. Scott
,
J. Cann
,
G. Kotovych
Journal of Biomolecular Structure and Dynamics
1993
Corpus ID: 37431787
The type II and type III collagen alpha-1 chain C-telopeptides are a 27 mer with the sequence NAc-GPGIDMSAFAGLGPREKGPDPLQYMRA and…
Expand
1989
1989
Covalent interactions of type IX collagen in cartilage.
J. J. Wu
,
D. Eyre
Connective Tissue Research
1989
Corpus ID: 27353356
The cross-linking of type IX collagen in fetal bovine cartilage was investigated. The main cross-link was dihydroxy…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE